Catechol-O-methyltransferase Val158Met genotype and the clinical responses to duloxetine treatment or plasma levels of 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in Japanese patients with major depressive disorder
Kiyokazu Atake, Reiji Yoshimura, Hikaru Hori, Asuka Katsuki, Jun Nakamura Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan Purpose: This study investigated the relationships among the plasma levels of catecholamine metabolites, the clinical...
Enregistré dans:
Auteurs principaux: | Atake K, Yoshimura R, Hori H, Katsuki A, Nakamura J |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2015
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/cb00d7a23f6f452086acb0603aabc9da |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Affect-modulated startle: interactive influence of catechol-O-methyltransferase Val158Met genotype and childhood trauma.
par: Benedikt Klauke, et autres
Publié: (2012) -
The relationship between the val158met catechol-O-methyltransferase (COMT) polymorphism and irritable bowel syndrome.
par: Pontus Karling, et autres
Publié: (2011) -
The catechol-O-methyltransferase (COMT) val158met polymorphism affects brain responses to repeated painful stimuli.
par: Marco L Loggia, et autres
Publié: (2011) -
Catechol-O-methyltransferase Val158Met genotype in healthy and personality disorder individuals: Preliminary results from an examination of cognitive tests hypothetically differentially sensitive to dopamine functions
par: Winnie W Leung, et autres
Publié: (2007) -
COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study
par: Hayashi K, et autres
Publié: (2014)